China is working hard to unseat America as the world's biotech leader. It has spent years bolstering incentives and capacity ...

China's booming pharmaceutical industry is not being impacted by Beijing's ‌tightening scrutiny over deals involving ...

As large biopharma companies have increasingly turned to China for novel biotech innovation, political calls in the U.S. to ...

Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...

Biotech is increasingly financed, governed and regulated as though it were a mature pharmaceutical industry rather than a ...

China's ascent is forcing U.S. biotech companies and investors to pick a side: Is it an ally or an existential threat?

Drug companies have cut nearly 69,000 pharmaceutical jobs since the start of 2021. A single biotech job posting now attracts ...

Fierce Biotech sat down with Pavel Raifeld, CEO of Innoviva, to explore the dynamic landscape of the biotech industry. Throughout the conversation, Raifeld offers a unique perspective on the most ...

If you look at a stock chart mapping the performance of the State Street SPDR S&P Biotech exchange-traded fund since early 2021, it seems to tell a simple story: The biotech sector has been a disaster ...

F rom blockbuster drugs that garner media attention to smaller innovations that help millions maintain health, the biotech and pharmaceutical industries have an impact on everyone’s life. Meanwhile, ...

The pharmaceutical contract manufacturing market is driven by increased outsourcing of complex processes to CMOs, enabling ...